People who were hospitalized due to gastroparesis or bowel obstruction, who were diagnosed with NAION vision loss, ileus or pancreatitis, or who experienced pulmonary aspiration during surgery or while under anesthesia after using Ozempic, Wegovy, Saxenda, Victoza, or Mounjaro may be eligible for compensation
Table of Contents Why this conversation matters Guest snapshot Peptides 101 Safe, practical peptide picks Regulatory and safety landscape NAD, exosomes, and their place GLP1 medications and microdosing Practical care pathways Gut health as the foundation Hormone replacement therapy (HRT) for midlife women Exercise, resistance training, and practical tools Supplements and small wins Finding a clinician: what to look for Common myths and straightforward truths Patient stories and the human side Practical checklist for someone considering peptides or GLP1s Resources FAQ Final practical notes from our clinical experience Where to learn more Closing practical tip Why this conversation matters We are living through a moment when new metabolic and regenerative tools are more accessible than ever
There are already approved options, injectable and oral, that may be right for you now
Related articles: [1]
Ma T, Lu W, Wang Y, Qian P, Tian H, Gao X, et al
